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Prothrombin 2021OA Variant and Age at Thrombosis
Dear Sir,
In their paper on the prothrombin 2021 OA variant, Hillarp and col-
leagues confirm our report on an association of this mutation and the
risk of venous thrombosis (1). Among 99 consecutive Swedish patients
with deep-vein thrombosis, they found seven carriers (7.1%), exceed-
ing the prevalence of 1.8% in 282 controls. This yielded a relative risk
estimate of 4.2, which was very similar to the results we found in Dutch
patients (2). Interestingly, they found no carriers of the 20210-A allele
among patients aged less than 62 years, and they speculate whether the
prothrombin variant might lead to increased risks specificaHy among
older age groups.
The data from the Leiden Thrombophilia Study point otherwise: we
found carriers of the 20210A variant in all age groups, and, äs stated in
our paper, an association with the risk of thrombosis in all these age
groups. In thrombosis patients below 30 years of age, 6. l % (5 out of 82)
were carriers, in individuals aged 30-49 years, 7.8% (17 out of 218)
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were carriers, and among those aged over 50,4.1% (7 out of 171) were
carriers, whereas among controls we found 2.3% (11 out of 474) car-
riers. This shows that the prothrombin variant increases the risk among
the young and the old. The findings in the Swedish group are most like-
ly due to a very small number of young individuals among the 99 pa-
tients (the mean age was reported to be 64 years), although age-depen-
dent differences in other, environmental. risk factors between geo-
graphical areas cannot be ruled out äs an alternative explanation.
F. R. Rosendaal, H. L. Vos, S. L. Poort, R. M. Bertina
Departments of Haematology and Clinical Epidemiology, Leiden Uni-
versity Medical Centre, The Netherlands
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The 2021 OA Allele of Prothrombin Is not Found among Sickle Cell Disease
Patients from West Africa
Dear Sir,
A common genetic Variation m the 3'-untranslated region of the pro-
thrombin gene has recently been described and shown to be associated
with an increase in venous thrombosis (1). At the time of writing, little
is known about the ethnic distribution of this polymorphism bul it was
found to have an allele frequency of 1.2% in a population-based control
study from the Netherlands. Thrombotic evcnts are known to be in-
creased in patients with sickle cell disease (SCD) where they represent
an important cause of mortality (2). Activation of the coagulation
System is well documentcd in SCD and may contributc to painful vas-
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cular occlusive crises, during which it becomes rurther activated. We
are therefore interested in the possible implications of genetic throm-
botic risk factors among these patients which could potentially exacer-
bate their condition.
DNA samples were prepared from 120 patients with homozygous
sickle cell disease who are bcing closely monitored äs a pari of an SCD
cohort in Cotonou, Benin in West Africa. We have screened these
DNAs forthc20210A mutation of prothrombin tisinga Hincl Illsitear-
tifidally creatcd during PCR amplification of the appropruite region of
the gene, äs described ( l ) . None of the subjects \\ i thin this patient sam-
ple were found to have the mutation.
These Undings suggest that. äs for Factor V Leiden (3, 4), the
2021 OA prothrombin mutation is not common among people of West
African ongin and therefore does not eontnbutc to the phcnotype or act
äs a significant risk factor lor thrombosis among \ickle cell disease
patients.
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